Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Revive Therapeutics Ltd (RVV.CN)

Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study GlobeNewswire - Fri Nov 21, 11:07AM CST

TORONTO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research...

RVV.CN : 0.0250 (+66.67%)
RVVTF : 0.0150 (+59.57%)
Revive Therapeutics Announces Closing of Second Tranche of Private Placement GlobeNewswire - Fri Sep 19, 4:00PM CDT

TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing...

RVV.CN : 0.0250 (+66.67%)
RVVTF : 0.0150 (+59.57%)
Revive Therapeutics Announces Extension of Proposed Private Placement GlobeNewswire - Fri Sep 5, 6:50PM CDT

TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing...

RVV.CN : 0.0250 (+66.67%)
RVVTF : 0.0150 (+59.57%)
Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement GlobeNewswire - Mon Aug 11, 6:28PM CDT

TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“ Revive ” or the “ Company ”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to...

RVV.CN : 0.0250 (+66.67%)
RVVTF : 0.0150 (+59.57%)
Revive Therapeutics Announces Proposed Private Placement and Debt Settlement GlobeNewswire - Wed Jul 30, 7:21PM CDT

TORONTO, July 30, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing...

RVV.CN : 0.0250 (+66.67%)
RVVTF : 0.0150 (+59.57%)
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study GlobeNewswire - Tue Jul 8, 4:10PM CDT

RVV.CN : 0.0250 (+66.67%)
RVVTF : 0.0150 (+59.57%)
Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity GlobeNewswire - Thu Jun 26, 6:00AM CDT

RVV.CN : 0.0250 (+66.67%)
RVVTF : 0.0150 (+59.57%)
Revive Therapeutics Advances with Next-Generation Bucillamine Development GlobeNewswire - Wed Jun 4, 5:55AM CDT

RVV.CN : 0.0250 (+66.67%)
RVVTF : 0.0150 (+59.57%)
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure GlobeNewswire - Mon May 12, 1:07PM CDT

RVV.CN : 0.0250 (+66.67%)
RVVTF : 0.0150 (+59.57%)
Revive Therapeutics Announces Proposed Shares for Debt Transaction GlobeNewswire - Mon Apr 21, 3:30PM CDT

RVV.CN : 0.0250 (+66.67%)
RVVTF : 0.0150 (+59.57%)

Barchart Exclusives

Rate Decision, Tech Earnings and Other Key Things to Watch this Week Barchart - Sun Dec 7, 12:00PM CST
Markets face the year's final major policy week as the Federal Reserve's December meeting Wednesday afternoon will determine whether the central bank delivers another rate cut or pauses its easing cycle amid mixed economic signals and persistent inflation concerns. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot